Mass General, MIT team develops AI tool to predict lung cancer risk

David Baker, Demis Hassabis, and John Jumper receive 2024 Nobel Prize in Chemistry

David BakerPhoto credit: Niklas Elmehed © Nobel Prize OutreachDemis HassabisPhoto credit: Niklas Elmehed © Nobel Prize OutreachJohn M. JumperPhoto credit: Niklas Elmehed © Nobel Prize OutreachDavid Baker, Demis Hassabis, and John M. Jumper received the 2024 Nobel Prize in Chemistry for their work in protein design and prediction.

October 11, 2024

Vol.50 No.38

Cancer History Project Conversation with The Cancer Letter

Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer

On Nov. 24, 2003, an article in The Boston Globe told the story of a patient’s remarkable response to gefitinib, a drug that had recently been approved by FDA.

October 04, 2024

Vol.50 No.37

By Paul Goldberg and McKenzie Prillaman

In Brief

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Four NCI-designated cancer centers—Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins—have joined together and secured funding from AWS, Deloitte, Microsoft, and NVIDIA, to create the Cancer AI Alliance.

October 04, 2024

Vol.50 No.37

In Brief

Qure.ai completes $65M Series D funding round

Qure.ai has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the U.S. market and other countries, increase investment in foundational AI models, and enable complementary med-tech company acquisitions.

October 04, 2024

Vol.50 No.37

Clinical Roundup

Data validates multimodal AI biomarker’s ability to help inform treatment decisions omCSPC

New data validated a multimodal artificial intelligence-based biomarker’s ability to help inform treatment decisions for patients with oligometastatic castration-sensitive prostate cancer, including metastasis-directed therapy benefit.

October 04, 2024

Vol.50 No.37

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations

Artificial intelligence is starting to transform life sciences by accelerating drug discovery and development, optimizing clinical trials, and creating personalized treatments for cancer patients, speakers said at the Sept. 18 unveiling of the American Association for Cancer Research 2024 Cancer Progress Report.

September 20, 2024

Vol.50 No.35

By McKenzie Prillaman

Mass General, MIT team develops AI tool to predict lung cancer risk

YOU MAY BE INTERESTED IN

David Baker, Demis Hassabis, and John Jumper receive 2024 Nobel Prize in Chemistry

Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Qure.ai completes $65M Series D funding round

Data validates multimodal AI biomarker’s ability to help inform treatment decisions omCSPC

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login

Mass General, MIT team develops AI tool to predict lung cancer risk

YOU MAY BE INTERESTED IN

David Baker, Demis Hassabis, and John Jumper receive 2024 Nobel Prize in Chemistry

Tom Lynch reflects on discovery of the EGFR mutations’ role in lung cancer

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Qure.ai completes $65M Series D funding round

Data validates multimodal AI biomarker’s ability to help inform treatment decisions omCSPC

AACR progress report highlights AI’s role in research and clinical careObstacles to progress include systemic disparities and dwindling appropriations

Can you spare 10 minutes to complete a survey?

Login

AACR progress report highlights AI’s role in research and clinical care
Obstacles to progress include systemic disparities and dwindling appropriations